awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37718001-410810D3-0F14-48D6-9828-D52DCB78FD1F
Q37718001-410810D3-0F14-48D6-9828-D52DCB78FD1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37718001-410810D3-0F14-48D6-9828-D52DCB78FD1F
The efficacy and safety of apremilast, etanercept and placebo in patients with moderate-to-severe plaque psoriasis: 52-week results from a phase IIIb, randomized, placebo-controlled trial (LIBERATE)
P2860
Q37718001-410810D3-0F14-48D6-9828-D52DCB78FD1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37718001-410810D3-0F14-48D6-9828-D52DCB78FD1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8dfa3f2051c25e77f9e43e1733da4e1658eee6db
P2860
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2).